Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Medix (MDIX) - competitor to Healtheon - $0.25/share

No earlier versions found for this Subject.

Return to Medix (MDIX) - competitor to Healtheon - $0.25/share

Medix used to be a healthcare services company. But, it has a subsidiary called Cymedix Linx which is connecting payors, providers, and patients through an electronic commerce platform. Their technology is up and running. They have signed up 100k doctors through an agreement with Wellpoint. And, they are trading at $0.25 at a $5MM valuation. They have $20MM in revenues losing $2.5MM per year. It looks like they are bringing in an e-commerce management team, selling off the healthcare services assets to fund the e-commerce platform, and grow the company. It appears to have lots of potential.